Among the remaining four genes (CCND1, LMO1, MDM4, and NCOA3), we observed no amplification or overexpression of MDM4, which is amplified and overexpressed in glioma and retinoblastoma6, in our analysis of 1,454 tumors. This evidence concerns the gene MDM4 and glioma.